STD 12 Panel And Other Tests

After getting the 12-item sexually transmitted infection test, many people ask, "Have I now checked everything?" To put the conclusion first, the commonly performed 12-item test is mostly made up of items confirmed by discharge or urine, and outside of it there are separate infections that must be confirmed by blood. Syphilis, HIV, hepatitis B, and hepatitis C are representative. Because their progression speed and testing method differ from the 12-item panel, they must be looked after separately so as not to be missed. In the clinic, there are quite a few cases where people are "relieved because it's negative" without knowing this difference, and end up leaving out the truly important items. Today, I will lay out, item by item, the blood-based sexually transmitted infections worth additionally considering beyond the 12 items.

The standard sexually transmitted infection test panel and the blood STI test look at fundamentally different targets. Items often handled, such as chlamydia, gonorrhea, trichomonas, and ureaplasma, mainly look for the bacteria's genes or antigens in genital discharge or urine. In contrast, syphilis, HIV, and hepatitis B and C are methods that confirm in the blood the antibodies or viral markers the body has produced. Since the specimen itself differs, having done one test does not automatically include the other.

Another important point is the latency period and the asymptomatic period. The infections confirmed by blood often pass for a long time with almost no symptoms. Since there are no symptoms, it is easy to dismiss it as "this doesn't apply to me," but transmission or organ damage can progress in the meantime. The U.S. Centers for Disease Control and Prevention (CDC) recommends that sexually active adults check these blood items at least once (CDC, 2021).

If you are unsure of your own risk factors and the timing of your last test, organize in advance through a chat consultation which items are worth looking after.

Comparing the difference between the two test groups at a glance makes it clearer why the additional items are needed. The table below organizes the specimen, the confirmation method, and representative items.

As the table shows, the key point of blood STIs is that they can progress even when there are no symptoms. So to the question "Why even a blood test when nothing is uncomfortable?", the answer becomes that catching it when there are no symptoms is the very testing purpose of these items. The detailed items and a composition suited to your situation can be decided through a consultation at women's disease treatment care.

Syphilis is caused by a bacterium called Treponema pallidum and begins with a blood screening test. There is a reason the syphilis test has two stages. First, you screen with a non-treponemal test (RPR, VDRL), and if positive, you confirm with a treponemal-specific test. In special situations where neurosyphilis is suspected, a cerebrospinal fluid test is additionally considered.

What surprises patients most here is false positives. There are cases where the screening test comes out positive even without syphilis. The CDC presents factors that may be associated with false positives, including pregnancy, recent viral infection, other infections such as HIV, tuberculosis, and malaria, autoimmune diseases (lupus, rheumatoid arthritis, etc.), certain vaccinations, injection drug use, and old age (CDC, 2024). So a positive screening test is not by itself a confirmation of syphilis, and it is always confirmed with an additional test of high specificity.

• Screening test: first confirmation with RPR or VDRL
• Confirmatory test: distinguishing false positives with a treponemal-specific test
• Treatment evaluation: confirming response by changes in RPR/VDRL titer after administering penicillin-class antibiotics

Treatment proceeds with penicillin-class antibiotics, and whether treatment is going well is evaluated by blood test titer. The key is not to conclude based on the result of a single screening test alone.

HIV is the causative virus of acquired immunodeficiency syndrome (AIDS); it destroys CD4-positive T-lymphocytes, the immune cells, lowering immune function. In the early stage of infection, symptoms such as fever, muscle pain, loss of appetite, nausea, abdominal pain, and skin rash may appear, and there are also cases with no symptoms at all. In my clinical experience, this "asymptomatic" stretch is the biggest reason people put off testing.

Because symptoms are mild or absent, the CDC recommends that those between 13 and 64 years old get an HIV test at least once in their lifetime, regardless of risk factors (CDC, 2021). When immunity is lowered, infections or tumors that would normally not be a problem can arise and threaten health, so confirming early becomes the starting point of management. It is good to remember that HIV is also confirmed by blood, so it is a separate item from the 12-item discharge test.

If the testing interval or interpretation of results feels daunting, I recommend referring to frequently asked questions about sexually transmitted infections or organizing it together during a visit.

Hepatitis B and hepatitis C are conditions that cause inflammation in the liver, and both can be transmitted through sexual contact. Hepatitis B is transmitted by body fluids such as blood and semen and by vertical transmission (mother-to-child transmission at birth). Some cases of acute hepatitis B transition to chronic, and if the chronic state persists, it can progress to cirrhosis or hepatocellular carcinoma, so caution is needed.

Hepatitis C can also be transmitted through blood and semen, and through blood-contact routes such as sharing needles or razors, tattooing, and ear piercing. The fact that both hepatitis types often pass for a long time without symptoms is important from an STI perspective.

Recent recommendations are increasingly heading toward broader testing. The CDC recommends a hepatitis B test at least once in the lifetime for adults aged 18 and older (CDC, 2023), and the U.S. Preventive Services Task Force (USPSTF) recommends a one-time hepatitis C test for all adults aged 18 to 79 (USPSTF, 2020). Checking these items together with safe sex habits lets you look after liver health as well.

Not everyone should get all items on the same schedule. Recommendations differ by risk factors and life stage. Generalizing the CDC recommendations, it can be organized as follows (CDC, 2021).

• HIV: those 13 to 64 at least once in a lifetime, more often if there are risk factors
• Syphilis: recommended for many sexually active adults depending on risk factors or regional prevalence
• Hepatitis B: adults 18 and older at least once in a lifetime (CDC, 2023)
• Hepatitis C: adults 18 to 79 at least once in a lifetime, periodic retesting if risk persists
• Pregnant women: recommended to receive syphilis, HIV, and hepatitis B tests in early pregnancy

If you have a new partner, have had a blood-exposure route such as needles or tattoos, or are planning pregnancy, it helps to check the additional blood items together. If you are curious about a composition suited to your situation, you can receive guidance on stage-specific tests at the pregnancy and contraception clinic or life-stage screening.

More important than the test is how you read the results and decide on the next action. Even if negative, you discuss the timing of retesting considering the latency period, and if positive or a false positive is suspected, the principle is to take the next step with a confirmatory test. Like syphilis's two-stage test, a procedure of not concluding based on a single result reduces unnecessary worry and overinterpretation.

The general pattern I often see in the clinic is that the more a person has looked after the additional blood items, the much calmer the interpretation of results and subsequent management proceeds. By going one step further from the 12-item test to also check syphilis, HIV, and hepatitis B and C, you come closer to the original purpose of testing, which is to confirm in advance when there are no symptoms.

Written by: Lee Dong-hee Director · OB-GYN specialist · View doctor profile

First published June 6, 2024 · Last reviewed May 30, 2026

References: CDC STI Treatment Guidelines (2021), CDC Laboratory Recommendations for Syphilis Testing (2024), CDC Hepatitis B Screening Recommendations (2023), USPSTF Hepatitis C Screening (2020)

This article is intended to provide general health information and does not replace individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.